09/2020: New method for EPO purification patented by UGA Biopharma

We have developed a newly patented method for the purification of the evolutionarily conserved hormone Erythropoietin (EPO) and its derivatives.

The innovative method and installation for purifying EPO and/or EPO derivatives was developed by two UGA employees, Wiebke Hannemann and Jenny Hessler. It makes the EPO purification process easier, more cost effective and environmentally friendly.

The patent for this method has been lodged with the European Patent Office and published as EP3613486A1 (See Resources).

For more information, please click here.




Contact

UGA Biopharma GmbH
Neuendorfstraße 20a
16761 Hennigsdorf
Germany
E-mail:  info@ugabiopharma.com This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone: +49(0)3302 / 2024900